Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population

about

Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population

Item

http://www.wikidata.org/entity/Q36611995

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Association of apolipoprotein ...... orthern Han Chinese population

@ast

Association of apolipoprotein ...... orthern Han Chinese population

@en

type

Item

label

Association of apolipoprotein ...... orthern Han Chinese population

@ast

Association of apolipoprotein ...... orthern Han Chinese population

@en

prefLabel

Association of apolipoprotein ...... orthern Han Chinese population

@ast

Association of apolipoprotein ...... orthern Han Chinese population

@en

P1476

Association of apolipoprotein ...... orthern Han Chinese population

@en

P2093

Kui Zhang

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Ran Dong

http://www.w3.org/2001/XMLSchema#string

Rui Liu

http://www.w3.org/2001/XMLSchema#string

Xiao-dong Pan

http://www.w3.org/2001/XMLSchema#string

Xin-miao Shi

http://www.w3.org/2001/XMLSchema#string

Zhi-zhong Gong

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Emergency hospitalizations for adverse drug events in older Americans

Estimation of the warfarin dose with clinical and pharmacogenetic data.

A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients

Genetic warfarin dosing: tables versus algorithms.

Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China.

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

The largest prospective warfarin-treated cohort supports genetic forecasting

P2888

s12944-016-0205-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12944-016-0205-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295829748

http://www.w3.org/2001/XMLSchema#string

P6179

1024118662

http://www.w3.org/2001/XMLSchema#string

P698

26912074

http://www.w3.org/2001/XMLSchema#string

P932

4765220

http://www.w3.org/2001/XMLSchema#string